BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20833935)

  • 1. Management of psychosis associated with a prolactinoma: case report and review of the literature.
    Ali S; Miller KK; Freudenreich O
    Psychosomatics; 2010; 51(5):370-6. PubMed ID: 20833935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
    Konopelska S; Quinkler M; Strasburger CJ; Ventz M
    J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on prolactinomas. Part 1: Clinical manifestations and diagnostic challenges.
    Wong A; Eloy JA; Couldwell WT; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1562-7. PubMed ID: 26256063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin, prolactin disorders, and dopamine agonists during pregnancy.
    Levin G; Rottenstreich A
    Hormones (Athens); 2019 Jun; 18(2):137-139. PubMed ID: 30341577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year follow-up of a giant prolactinoma.
    Fernandes V; Santos MJ; Almeida R; Marques O
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26590188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder.
    Melkersson K; Hulting AL
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(1):6-10. PubMed ID: 10738858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.
    Freeman B; Levy W; Gorman JM
    J Psychiatr Pract; 2007 Mar; 13(2):120-4. PubMed ID: 17414690
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis.
    Broekhof R; Gosselink MJ; Pijl H; Giltay EJ
    Gen Hosp Psychiatry; 2012; 34(2):209.e1-3. PubMed ID: 21872335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on prolactinomas. Part 2: Treatment and management strategies.
    Wong A; Eloy JA; Couldwell WT; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Surgery in the Management of Prolactinomas.
    Donoho DA; Laws ER
    Neurosurg Clin N Am; 2019 Oct; 30(4):509-514. PubMed ID: 31471058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice. Prolactinoma.
    Schlechte JA
    N Engl J Med; 2003 Nov; 349(21):2035-41. PubMed ID: 14627789
    [No Abstract]   [Full Text] [Related]  

  • 12. Mucocele-like formation leading to neurological symptoms in prolactin-secreting pituitary adenomas under dopamine agonist therapy.
    Abe T; Lüdecke DK
    Surg Neurol; 1999 Sep; 52(3):274-9. PubMed ID: 10511086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of pediatric atypical prolactinoma: significance of a multidisciplinary treatment approach.
    Inoue A; Ohnishi T; Kohno S; Kitazawa R; Mizuno Y; Nishikawa M; Ohue S
    Clin Neurol Neurosurg; 2014 Sep; 124():138-41. PubMed ID: 25048518
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term management of prolactinomas--use of long-acting dopamine agonists.
    Cook DM
    Rev Endocr Metab Disord; 2005 Jan; 6(1):15-21. PubMed ID: 15711910
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis.
    Tsigkaropoulou E; Peppa M; Zompola C; Rizos E; Xelioti I; Chatziioannou S; Filippopoulou A; Lykouras L
    Gend Med; 2012 Feb; 9(1):56-60. PubMed ID: 22333523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma.
    Hong JW; Lee MK; Kim SH; Lee EJ
    Endocrine; 2010 Feb; 37(1):140-7. PubMed ID: 20963563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proptosis as the presenting sign of giant prolactinoma in a prepubertal boy: successful resolution of hydrocephalus by use of medical therapy.
    Cackett P; Eunson G; Bath L; Mulvihill A
    Future Oncol; 2012 Dec; 8(12):1621-6. PubMed ID: 23231524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selection of management tactics in treatment of giant prolactin-secreting pituitary adenomas].
    Astaf'eva LI; Kadashev BA; Kalinin PL; Kutin MA; Faĭzullaev RB; Sidneva IuG; Tenedieva VD; Tropinskaia OF
    Zh Vopr Neirokhir Im N N Burdenko; 2009; (2):23-8; discussion 28-9. PubMed ID: 19569545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUCCESSFUL TREATMENT OF A PROLACTINOMA (CASE REPORT).
    Pasyechko N; Naumova L; Krytskyy T; Kulchinska V
    Georgian Med News; 2019 Feb; (287):26-29. PubMed ID: 30958283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A giant prolactinoma presenting with unilateral exophthalmos: effect of cabergoline and review of the literature.
    Berwaerts J; Verhelst J; Abs R; Appel B; Mahler C
    J Endocrinol Invest; 2000 Jun; 23(6):393-8. PubMed ID: 10908167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.